ST-100 shows promise as a fast-acting treatment for dry eye disease, offering rapid relief and unique collagen repair ...

FYB203 has been approved by the US FDA and UK Medicines and Healthcare products Regulatory Agency for the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular edema, ...

Perfuse Therapeutics reveals promising Phase 2 trial results for PER-001, a potential treatment for glaucoma and diabetic ...

ForSight Robotics secures $125M to advance its robotic surgery platform, targeting cataract procedures and additional ...

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.

As its director, Manusis outlines the facility’s role in delivering advanced, personalized solutions to improve vision and ...

From laser vision correction to adjustable lens implants, the Center for Refractive Solutions at New York Eye and Ear ...

Assistive devices empower patients with central vision loss to regain independence, enhancing daily activities and reducing ...

To conduct the study, the investigators obtained data on coffee consumption from genome‐wide association studies (GWAS) and ...

Funding will support continued product development, while the board is composed of “global leaders in posterior and anterior ...

A look at current therapies, clinical trial results, patient education, and emerging options for managing this progressive ...

Kira Manusis, MD, is Director of the Center for Refractive Solutions and Co-Director of Cataract Services at NYEE.